Cardiovascular mortality and dialysis access-related infections: is there a link?

[1]  A. Nissenson,et al.  Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  R. Foley,et al.  Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. , 2005, Kidney international.

[3]  K. D. Workgroup.  K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  C. Tetta,et al.  Is biofilm a cause of silent chronic inflammation in haemodialysis patients? A fascinating working hypothesis. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  R. Schindler,et al.  Short bacterial DNA fragments: detection in dialysate and induction of cytokines. , 2004, Journal of the American Society of Nephrology : JASN.

[6]  Peter Stenvinkel,et al.  The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. , 2002, Kidney international.

[7]  Anand Kumar,et al.  Clinical review: Myocardial depression in sepsis and septic shock , 2002, Critical care.

[8]  A. Saxena,et al.  Outcome of Dialysis Access-Related Septicemia among Diabetics following Optimized AV-Fistula Placement , 2002, Kidney and Blood Pressure Research.

[9]  S. Fishbane,et al.  Occult infection of old nonfunctioning arteriovenous grafts: a novel cause of erythropoietin resistance and chronic inflammation in hemodialysis patients. , 2002, Kidney international. Supplement.

[10]  A. Saxena,et al.  The impact of achieving the target goal for AV fistulas, as set by NKF-DOQI, on Staphylococcus aureus septicemia , 2002 .

[11]  E. Lowrie,et al.  Cardiovascular Disease in Dialysis Patients , 1974 .